Tabunda, Lyqa Czyriel C.
HRN: 21-84-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/25/2022
08/31/2022
IV
440mg
Q8
Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes